Pharmacodiagnostics and Targeted Therapies—A Rational Approach for Individualizing Medical Anticancer Therapy in Breast Cancer-Reference-Cited by-同舟云学术

Pharmacodiagnostics and Targeted Therapies—A Rational Approach for Individualizing Medical Anticancer Therapy in Breast Cancer

Published:2007-04-01 Issue:4 Volume:12 Page:397-405
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Jørgensen Jan Trøst¹,Nielsen Kirsten Vang¹,Ejlertsen Bent²

Affiliation:

1. a Clinical Research, Dako Denmark A/S, Glostrup, Denmark

2. b Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Abstract

Learning Objectives After completing this course, the reader will be able to: Assess the predictive biomarkers currently used in breast cancer, including, for example, ER, HER-2, and TOP2A.Discuss the predictive capability of biomarkers in relation to the mechanisms of action of the corresponding treatment.Discuss the link between the targeted therapies currently used in breast cancer and the predictive biomarkers.Evaluate the role of TOP2A testing in relation to treatment with anthracyclines. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-4-397

Reference50 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group (EBCTCG);Lancet,2005

2. Intervention research in rational use of drugs: A review;Grand;Health Policy Plan,1999

3. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

4. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

5. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuromonitoring: No Longer a Spectator Sport;Neurocritical Care;2020-04-06

2. Review of fluorescent steroidal ligands for the estrogen receptor 1995–2018;Steroids;2019-04

3. Topoisomerase II-alfa gene as a predictive marker of response to anthracyclines in breast cancer;Pathology - Research and Practice;2014-10

4. Maximizing the commercial value of personalized therapeutics and companion diagnostics;Nature Biotechnology;2013-09

5. Her2 Amplification in Gastric Cancer Is a Rare Event Restricted to the Intestinal Phenotype;International Journal of Surgical Pathology;2013-04-05